Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lanreotide Maintenance Therapy in Non-resectable Duodeno-pancreatic Neuroendocrine Tumours After First-line Treatment
2013-004069-14Phase 2Completed
- Sponsor
- Fédération Francophone de Cancérologie Digestive
- Start
- Sep 2014
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in islet cell tumor and Duodenal carcinoid tumor comparing Lanreotide maintenance with Placebo (2 arms). Started Sep 2014; status: completed.
02
Drugs
lanreotide
03
Conditions
islet cell tumorDuodenal carcinoid tumor
Beyond the preview
Go deeper on 2013-004069-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004069-14.